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An Assessment of Anti-Staphylococcal, Anti-Mycobacterial and Anti-Candidal Properties in 
Fungal Isolates of the Big Brown Bat (Eptesicus fuscus) Microbiome 
 
by Vanessa Noujaim 
 
ABSTRACT 
Antibiotic resistance is becoming an increasing problem in global health. The emergence of 
antibiotic-resistant bacterial and fungal infections is expected to increase over the next few years. 
In an effort to develop therapies to counteract this issue, previously unexplored environmental 
microbes are assessed in their anti-candidal, anti-staphylococcal and anti-mycobacterial 
properties. Five strains from the big brown bat microbiome are cross-cultured with three 
pathogenic strains: Staphylococcus aureus, Mycobacterium smegmatis, and Candida albicans. 
These pathogenic strains act as proxies for antibiotic-resistant pathogens. Working under the 
presumption of quorum-sensing occurring between microbes in close proximity, cross-cultures 
are conducted with the intent of activating dormant pathways. Bat strain growth and phenotypic 
changes are assessed in these cross-cultures and the possibilities of anti-pathogenic properties in 
bat strains are determined based on these findings. Two of the five bat strains studied have a 
strong likelihood of possessing anti-pathogenic properties. The remaining bat strains show 
promise in further investigations as well, but not to the same extent based on findings. 
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List of Abbreviations 
WNS: White-nose Syndrome  
QS: Quorum-sensing 










Modern medicine was initiated by the revolutionary discovery of antibiotics in the 1930's. Since 
then, antibiotic resistance has been mounting into a significant threat to the provision of 
healthcare. The World Health Organization maintains that antibiotic resistance is one of the 
largest threats to global health and food security (WHO 2018). This identified global epidemic 
has also placed a rather heavy economic strain on healthcare systems around the world, including 
that of Canada. The adaptation of microbes, bacteria in particular, to resist these anti-microbial 
compounds is a natural and rapid process. Bacteria have the ability to freely hybridize; genes can 
be transferred laterally between unrelated species via plasmids and conjugation. DNA in the 
extracellular environment can also be incorporated into the bacterial genome through the process 
of transformation. Even more, transduction facilitates mutation and adaptation where 
bacteriophages can carry and inject fragments of DNA from bacterium to bacterium. The 
increase in intensity of antibiotic resistance among pathogens is thus the inevitable result of  
antibiotic use. 
 However, the rate of acquired resistance in microbes is exacerbated by human activity: 
over-prescription of antibiotics, animal farming, poor sanitation and sewage treatment and 
increased international travel (Webster 2017; Aslam et al., 2018). This extensive use of 
antibiotics in such human interventions has created a strong selection pressure in environmental 
microbes (Thereutzbacher et al. 2019). The development of antibiotics indeed revolutionized 
medicine, and as such there is a real concern for a return to the pre-antibiotic age - in which the 
success rates of major procedures such as surgery and organ transplants will regress (Aslam et al. 
2018). Given that these antibiotic-resistant (AR) microbes are slowly but surely pushing the state 
of healthcare back into a pre-modern age, there indeed is an indisputable need for the 
development of new antibiotics. 
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 Traditionally, antibiotics have been isolated and developed from natural sources, such as 
environmental fungal strains, soil bacteria and aquatic organisms. Antibiotics are derived from 
secondary metabolites: compounds produced by an organism that do not have a direct effect on 
their own growth or reproduction (Bertrand et al., 2014). The natural products produced by 
actinomycetes and streptomycetes - classes of bacteria found in soil - are some of the primary 
sources for antibiotics (Malloy & Hertweck 2017; Bills, Bluer & An, 2013). Generally, these 
species are grown in monoculture that induces stress, such as lack of essential nutrients, 
temperature or pH alterations (Gould, Gunesekera & Khan 2019). These same products have 
been continuously tweaked to evade the acquired drug resistance of pathogenic microbes. This 
includes combining known antibiotics that possess different mechanisms of action or altering 
functional groups (Gould, Gunesekera & Khan 2019). Novel antibiotic production, however is at 
a stand-still; antibiotics developed in the last thirty years are merely variations of previously 
discovered products (Conly & Johnstone 2005; Gould, Gunasekera & Khan 2019). The 
discovery and development of new antibiotics has reached a lull for a variety of reasons. 
However, a fundamental issue in this is the lack of incentive for pharmaceutical companies to 
invest in the development of a drug that will prove to be ineffective after a short number of years 
(Theuretzbacher et al. 2019; Gould, Gunasekera & Khan 2019). New treatments for infections 
are virtually limited and the prevalence of AR microbes or 'superbugs' are on the rise. AR 
microbes are now developing a resistance to the 'last resort' drugs such as vancomycin (Aslan et 
al. 2018; Roemer, Schneider & Pinho 2014). 
 The harsh reality that acts as a deterrent in antibiotic development is the unfavourable 
cost and time invested into getting an antibiotic on the market, only for resistance to develop less 
than a year into its therapeutic use (Conly & Johnston 2005; Saha & Mukherjee 2019). 
Consequently, minimal resources are dedicated to antibiotic research, although some 
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organizations are recognizing the severity of the matter and have begun introducing some 
incentives (Conly & Johnston 2005; Aslam et al. 2018). Avenues that show promise for 
antimicrobial treatments have emerged nonetheless, such as nanotechnology and engineered 
bacteriophages (Kalhapure et al. 2014; Saha & Mukhurjee 2019). These developments also 
address the issue of the lack of specificity of some antibiotics. Broad-specificity antibiotics 
eliminate both detrimental and beneficial microbes in the human microbiome which provides an 
opportunity for the resistant strains to take root in this new, non-competitive environment.  
 Antibiotics have commonly been isolated from microbes that are in a laboratory 
monoculture, outside of their ecological context. In this process, innate secondary metabolites - 
products that are secreted by an organism in absence or response to an environmental stress - are 
extracted. That is, some secondary metabolites are secreted into the extracellular environment as 
chemical messengers and a stress such as competition does not need to be present for this to 
occur. However. the full 'biosynthetic potential' of these microbes is thus unrealized  when they 
are grown in monoculture, since there are dormant pathways that are not expressed under 
laboratory conditions but rather are expressed in the natural environment in the presence of other 
microbes. Even well-studied microorganisms have vast quantities of undocumented biochemical 
pathways (Malloy & Hertweck 2017). The importance of emergent properties in the natural 
environment of microbes is exemplified by the human microbiome, where beneficial products 
are produced by the diverse population of bacteria in the gut and aid in immune defence (Braga, 
Dourado & Araujo 2016). Some diseases in humans arise due to an imbalance in the microbiota, 
because pathogens can maintain their colonization and infection of the host when it can 
successfully compete against commensal bacteria (Braga et al. 2016). In this lies the importance 
of emulating the natural environment as a means of unlocking novel secondary metabolite 
production.  
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 Microbes have a complex mechanism of communicating and behaving with nearby 
organisms in its environment, referred to as quorum-sensing (QS). There is substantial literature 
on QS in colonies of bacteria, while QS in fungi represents a much more recent discovery 
(Barruso et al. 2018; Malloy & Hertweck 2017; Albuquerque & Casadevall 2012). Overall, QS 
involves the process of natural product secretion into the immediate extracellular environment 
(ECE) which are then detected by other organisms, and a course of action is taken depending on 
cell density (Bertrand et al, 2014). These microbes communicate through hormone-like 
molecules called quorum-sensing molecules (QSM) or 'autoinducers' (Albuquerque & 
Casadevall 2012). Microbes choose to ignore, cooperate or eliminate their neighbouring 
microbes in the ECE based on the number of signals received, which is proportional to the 
population density. Biofilm formation, competition and virulence factors in bacterial populations 
are facilitated by QS. In fungi, QSM have been observed to induce effects on its host and aid in 
its pathogenicity (Albuquerque & Casadevall 2012). Biofilm can also occur in a mixed form of 
both fungi and bacteria (Frey-Klett et al. 2011). In some cases, fungi provide 'biotic support' and 
facilitate biofilm establishment in bacteria (Frey-Klett et al. 2011). The interactions between 
bacteria, fungi and other microbes, for that matter, are comprehensive as well as innate in the 
natural environment. 
 Traditional antibiotics derived from natural products are a result of the isolation of innate 
QSM found in monocultures of various microbial strains. Interestingly, these innate QSM 
function as messengers in the ECE and are emitted at sub-lethal concentrations (Braga et al. 
2016; Malloy & Hertweck 2017). Therefore, there are a plethora of natural products that could 
theoretically act as an effective, targeted antibiotic since these are secreted in response to a threat 
or competition in the environment. These induced secondary metabolites are 'defence antibiotics' 
while the innate metabolites are 'signaling antibiotics' (Malloy & Hertweck 2017). A certain 
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microbe's signalling antibiotic could also be a secretion of a lower concentration of its defence 
antibiotic (Malloy & Hertweck 2017; Bertrand et al., 2014). 
 With the knowledge that microbial interactions activate dormant pathways and incites the 
production of secondary metabolites that aid in the microbes' survival, one of the intentions of 
this experiment is to emulate the idea of the QS stimuli-response system in a controlled 
laboratory setting.  
 Three microbial strains will be used as a proxy or representative for pathogenic strains 
that are heightening in MDR; these pathogenic strains are Methicillin-resistant Staphylococcus 
aureus (MRSA), Mycobacterium tuberculosis and Candida auris. The MDR of MRSA and M. 
tuberculosis have been well-documented over the years. The first strain of MRSA was isolated in 
1971, a couple decades after the realization was made that bacterial defences could evade the 
effects of antibiotics over time (Roemer, Schneider & Pinho 2013). MRSA infections are 
prevalent in hospitals, specifically in patients who are immunocompromised (Webster 2017). M. 
tuberculosis has also represented a rising issue in global health, though more recently there have 
been concerns over the lack of treatments for this particular infection. Conversely, Candida auris 
has been a more recent discovery, where it was first isolated in Japan and described in 2009 
(Lone & Ahmad 2018). In 2017, the first case of MDR C. auris was reported in Canada (Lone & 
Ahmad 2018). Currently, there are no documented reliable therapeutic interventions for C. auris 
infections. This, in part, is due to the difficulty in differentiating it from related Candida species 
such as Candida albicans (Lone & Ahmad 2018). Thus, a need for effective anti-fungal 
treatments are highlighted. 
 Our experiments are conducted in a Containment Level 2 laboratory. As such, 
Staphylococcus aureus, Mycobacterium smegmatis and Candida albicans will act as the 
'pathogenic strains' in place of MRSA, M. tuberculosis and C. auris respectively. The proxy 
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strains will then be inoculated on the same agar plate as the environmental strains. The 
environmental strains are retrieved from the microbial library of White-Nose Syndrome (WNS) 
resistant big brown bats (Eptesicus fuscus) compiled by Kolwich (2019). Dr. Paul Faure's group 
at the McMaster University Bat Lab sampled WNS-resistant big brown bats by swabbing the 
muzzle and the length of the forearms (Kolwich 2019). Pure microbial strains obtained from Dr. 
Myron Smith's lab at Carleton University will also be used in screening environmental microbes 
for potential antimicrobial properties. These strains were gathered from the soil and caves that 
serve as locations of hibernation for big brown bats.  
Two strains from the Faure lab – F1, F3 – and three strains from the Smith lab – S2, S8, 
S9 – were selected for use in this experiment based on their anti-pathogenic performance against 
Pseudogymnoascus destructans, the fungus that causes WNS (Kolwich. 2019). These strains 
were isolated and have been identified by Kolwich to date as the following: 
▪ F1 - Trichoderma sp. 
▪ F3 – Didymella sp. 
▪ S2 – Unknown 
▪ S8 – Unknown 
▪ S9 – Penicillium canescens  
From here on, they will be referred to by using their original denotations: F1, F3, S2, S8, and S9. 
 Strains from the big brown bat epidermal microbiome and habitat are being screened 
against the pathogenic strains for anti-candidal, anti-staphylococcal and anti-mycobacterial 
properties for a few fundamental reasons. Firstly, the big brown bat poses as an unexplored area 
for potential antibiotics against human pathogens. It is evident that other sources of natural 
products should be examined since they represent an opportunity for the discovery of novel 
antimicrobial products. Secondly, the immunity of big brown bats against fungal infections is 
primarily dependent on their 'immuno-microbiome' rather than their biological immune system 
(Horrocks, Matson & Tieleman 2011). The microbes in and around their skin are the primary 
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defence for warding off fungal infections (Horrocks, Matson & Tieleman 2011). The strains 
obtained from the big brown bat essentially show promise in functioning against human 
pathogenic strains - bacterial and fungal - if their microbiota already shows a strong resistance to 
infection.  
 Bat strains that induce phenotypic variation and/or growth impediments in the pathogenic 
strains and/or demonstrate phenotypic variation in themselves will be identified as having 
potentially beneficial secondary metabolite production. These noted strains can be examined 
within future investigations in order to further isolate and identify the secondary metabolites in 
question. There also remains the question of if these secondary metabolites secreted by the 
environmental strains are induced or remain innate even in the presence of another microbe. 
Another question that should be addressed in further studies is the effectiveness of these 
environmental strains' defence mechanisms against the true pathogens in question - MRSA, M. 
tuberculosis, C. auris - since they possess unique characteristics that contribute to their 
pathogenicity.  
 In congruence with determining novel and effective antimicrobial products, this study 
aims to investigate a potential avenue for antibiotic discovery by inducing secondary metabolite 
production in co-cultures. The overall objective of this experiment is to conduct a baseline 
screening of anti-candidal, anti-mycobacterial and anti-staphylococcal properties in previously 
unexplored environmental strains from big brown bats and their habitats 
 
MATERIALS AND METHODS 
 
Materials: 
Candida albicans (ATCC #10231), Staphylococcus aureus (ATCC #12600) and Mycobacterium 




Collection. The F1 and F3 bat strains, which originated from the Faure Lab, were obtained from 
the preceding Kolwich project. The S2, S8 and S9 bat strains, which originated from the Smith 
Lab, were also obtained from the Kolwich project. Yeast malt agar was used as the growth 
medium in Petri dish cultures, the proportions being: 20g agar powder, 21g yeast malt powder 




1-3-month-old stocks of pathogens and bat strains grown on YMA plates from freezer stocks 
were used to conduct CC trials.  
Two sets of CCs for each pathogen were conducted. One set remained at room temperature 
(about 21°C); the other set was incubated at 37°C.  
 
Monocultures of the pathogens and 
bat strains acted as controls for this 
experiment. These monocultures 
were first grown at their ideal 
temperature for 7 days (Table 1), 
after which they remained at room 
temperature for the entirety of the 
experiment. The site of inoculation 
(SOI) for these monocultures was at the 
pole or end of the plate (Figure 1). 
Figure 1: A diagram representing monocultures 
and cross-cultures of pathogens and bat strains, 
specifically the site of inoculation at either pole 
of the plate 
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In order to account for differences in growth rate among the pathogens and bat strains, some 
strains were given a ‘head-start’ to grow on the plate. S. aureus, M. smegmatis and bat strains (to 
be crossed with C. albicans) were inoculated and left to incubate at their ideal temperatures 
(Table 1). After 48 hours, CCs were completed for S. aureus and the bat strains, by inoculating 
the bat strains on the original S. aureus plates and C. albicans on the original bat strain plates. 
After 72-96 hours, M. smegmatis CCs were completed by inoculating the bat strains.  
Growth and other phenotypic characteristics (color, structure) were observed at the 2-day mark, 
5-day mark and 7-day mark after completion of CCs. 
An approximate area of each monoculture and each strain in CC was measured on the 8th day. 
Strains were measured in a rectangular area that loosely fit the actual area. For S. aureus and M. 
smegmatis, where growth is in distinct colonies, a rectangular area was measured based on how 
far the bacterial colonies reached (Figure 2). A percentage of growth in CC was calculated for 
each strain in a CC using these values (Equation 1).  
 
Figure 2: A diagram of the proposed method for approximate area measurement of A) 
bacterial/yeast growth and B) mold growth in monoculture and CCs.  
 
Equation 1: Percentage growth = area of strain in cross-culture 







Table 1: A qualitative growth profile of pathogens and bat strains gathered from experimental 
observation. The following data are approximations based on the environmental parameters that 
were set up for the experiment. Temperatures below 21°C were not tested, though it is believed 
that S2, S8, and S9 grow optimally in lower temperatures based on previous trials (Kolwich, 
2018). Slow growth rate indicates any growth observed beyond 72 hours, mediocre growth rate 
indicates any growth observed between 24-72 hours, and fast growth rate is any growth observed 

















N Mediocre 37°C 
Mycobacterium 
smegmatis 
N Slow 37°C 
Candida 
albicans 
Y Fast 37°C 




S2 Y Mediocre 21°C 
S8 Y Fast 21°C 





Table 2: A general description of pathogen and bat strain phenotypes in both monocultures and 
cross-cultures. Bat strain phenotypes remained relatively consistent in all three pathogenic cross-
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cultures, with a few exceptions which are noted in more detail in Table 3. The following 
summarizes the observed characteristics. ‘Optimal conditions’ and ‘Early stages of growth’ are 
indicative of phenotypic characteristics in monoculture, whereas ‘Stressful conditions’ is 
indicative of general observations of cross-cultures at the 7-day mark. Fungal strains in particular 
have distinct phenotypic changes at different stages of growth unlike bacterial strains. 





Isolated, small, yellow-white 
circular colonies  
No change observed None 
Mycobacterium 
smegmatis 
Colonies are connected, 
sometimes circular; white-yellow 
in color with a smooth texture 
No change observed None 
Candida albicans Irregular appearance; creamy, 
white to beige and flat. 
 
Circular colonies scattered 
throughout in an irregular fashion 
 
Absence of mycelium 
Mycelium visible 
 
Absence of circular 
colonies; only flat, 
cream-white swashes 
of growth 
F1 Brown-green, flat, moss-like 
appearance 
 
Color of YMA is brown 
 
Clear yellow crystals present in 
mature cultures 
 
Fungus colored green with 
small buds, turns to white as it 
extends outwards 
Green outgrowths of 
hyphae-like structures 





F3 Color of YMA is dark brown-
orange-yellow; brown at SOI and 
fades into yellow as hyphae 
extend from SOI 
Clear orange crystals embedded 
in white puffy substances. 
 
Absence of crystals Absence of crystals  




Color of YMA is pink-orange 
Media is stained dark pink at 
site of interaction with 













Orange-yellow mold like 
appearance with flecks of white 
fuzz  
 
Color of YMA is yellow-orange 
 
Presence of purple-pink hyphae 
at outer edges of growth 


















S9 SOI is pink with white, fluffy 
hair-like extensions growing 
upwards 
 
Color of YMA is pink at SOI; 
pink-orange elsewhere 
Media is stained pink at point 
of inoculation and at site of 




Figure 3: Cross-cultures at 21°C after 7 days of growth. Pathogens for each vertical row are 
indicated at columns, and bat strains are indicated at the rows. Photo A) shows cross-cultures 
from under the plate, with bat strains on the upper half of the plate and pathogenic strains on the 
lower half of the plate; Photo B) shows cross-cultures from the top of the plate, with pathogenic 
strains displayed on the upper half of the plate and bat strains displayed on the lower half of the 
plate. 
  










Figure 4: Cross-cultures at 37°C after 7 days of growth. Pathogens for each vertical row are 
indicated at columns, and bat strains are indicated at the rows. Photo A) shows cross-cultures 
from under the plate, with bat strains on the upper half of the plate and pathogenic strains on the 
lower half of the plate; Photo B) shows cross-cultures from the top of the plate, with pathogenic 



















Table 3: A summarization of phenotypic changes in cross-cultures at 21°C after 7 days. 
 
 










F1 covers plate. 
 
Small patch of 
light orange, 





with ‘buds’ (top) 
 




fading to yellow 
edges (bottom). 
White fuzz (top). 
 
Hyphae are thin 




S2 covers ½ plate. 
 
Dark pink-orange, 
fading to light 
pink-yellow 
(bottom).  
Pink fuzz fading to 
white fuzz (top). 
 
S. aur yellow in 
color at area of 
contact with S2; 
white in color 
elsewhere. 
 




with white edges 
(bottom). 
 
S9 covers 2/3 of 
plate.  
 




S.aur yellow in 
color in area of 
contact with S9; 










F1 covers plate. 
 
Small patch of 
light orange, 





with ‘buds’ (top) 
 




fading to yellow 
edges (bottom). 











close to edge 
(bottom).  
White fuzz with 
orange yellow 






S9 covers plate. 
 












F1 covers plate. 
 
Dark brown 
turning to light 




with ‘buds’ (top).  
 
 
F3 body covering 
about 1/3 of the 




F3 dark orange in 
color to yellow 
edges (bottom). 
White fuzz (top). 
 








S2 covers entire 
plate. Light pink in 
color.  
 
Very dark pink at 








S8 covers ¾ of 
plate 
 
Yellow, fading to 
light yellow, dark 
orange hyphae-like 
structures at the 
edge (bottom).  
 
No contact with 
C.alb 
 
S9 covers plate.  
 
Light pink with 
dark pink at area of 
contact with C.alb 
(bottom). White 
fuzz covering C.alb 
(top) 
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F1 covers plate. 
 
Green-brown 














Low growth of S2 
 
Low growth of S8 
 










F1 covers plate. 
 
Brown-orange-
green, fading out 
to light green 
and becoming 
darker again 








F3 covers less than 
¼ of plate. 
 
Dark-brown 
orange fading out 
to yellow 
(bottom). White 
fuzz (top).  
 
Hyphae extending 























C. alb  
 
F1 covers plate. 
 
Green-brown 
with patches of 
light yellow 






C.alb (top).  
 
F3 covers less than 




orange fading out 
to yellow 
(bottom). White 
fuzz (top).  
 
Hyphae extending 
out from body. 
 
 




No growth S8 
 
No growth of S9 
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Phenotype 
The appearance of F1 differed between temperatures; at 21°C, the majority of F1’s structure is 
composed of white buds (Table 3). At 37°C, F1 does not have white buds and is predominantly 
green (Table 4; Figure 4).  
S2 varied in colour composition in CC with S. aureus as opposed to CC with C. albicans. 
S2 is a dark pink in the presence of S. aureus and light pink in the presence of C. albicans (Table 
3; Figure 3). S2 within the C. albicans CC also appears to turn into a dark pink where it comes in 
contact with C. albicans (Table 3; Figure 3). When S2 comes into contact with S. aureus, this 
colour change is not observed. Rather, S. aureus changes colour from white to yellow when in 
contact with S2. These same observations between S2, S. aureus and C. albicans are seen with 
S9 (Table 3; Figure 3). 
F3 also differs in phenotypic structure. F3 does have hyphae with the M. smegmatis CC, 
but does produce hyphae when CCd with S. aureus and C. albicans (Table 3; Figure 3). In 
contrast, F3 is observed to have hyphae with M. smegmatis and C. albicans CC at 37°C (Table 4; 
Figure 4). There were no hyphae observed with F3 x S. aureus due to insufficient growth of F3 
(Table 4; Figure 7). 
C. albicans and S. aureus varied in structure between temperatures. C. albicans appears 
to have many more visible circular colonies covering more surface area at 21°C (Figure 3). At 
37°C, C. albicans is not as widespread, with little to no circular colonies (Figure 4). S. aureus 
appears as one fluid streak of bacterial growth at 21°C (Figure 3). At 37°C, S. aureus has distinct 
circular colonies (Figure 4).  
M.smegmatis growth was inconsistent across both temperature trials, though colonies appeared 













F1 F3 S2 S8 S9 
S. aur 5 5 4 4 4 
M.smeg 5 3 - 2 0 
C.albi 1 4 3 3 2 
 
Figure 5: A heat map displaying percent growth of pathogenic strains in cross-culture trials with 










Figure 6: A heat map displaying percent growth of pathogenic strains in cross-culture trials with 





No data    
No growth    
<1 - 5% growth    
6-24% growth   
25-50% growth    
51-74% growth    
75-100% growth    
 
F1 F3 S2 S8 S9 
S.aur 0 5 5 4 3 
M.smeg 0 4 5 5 - 












Figure 7: A heat map displaying percent growth of bat strains in cross-culture trials with 











Figure 8: A heat map displaying percent growth of bat strains in cross-culture trials with 
pathogenic strains at 37°C. 
 
 




S.aur M.smeg C.albi 
F1 5 5 5 
F3 2 4 5 
S2 4 - 5 
S8 3 5 5 
S9 5 5 5 
 
S.aur M.smeg C.albi 
F1 5 5 5 
F3 1 3 2 
S2 1 1 1 
S8 1 1 1 
S9 1 - 1 
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At 21°C, all bat strains showed 75-100% growth in C. albicans CCs (Figure 7). F1, S8 and S9 
showed 75-100% growth in M. smegmatis CCs (Figure 7). Finally, only F1 and S9 showed 75-
100% growth in S. aureus CCs (Figure 7). F1 and S9 were the only strains successful in 75-
100% growth within all three pathogenic CCs (Figure 7), 
At 37°C, S2, S8 and S9 showed little growth in all pathogenic CCs (Figure 8). F3 showed 
minimal growth in the S. aureus CC, compared to greater growth with M. smegmatis and C. 
albicans (Figure 8). F1 was the only bat strain in the 75-100% growth bracket for all three 
pathogens (Figure 8).  
Pathogens generally grew above the 25% mark in most CCs with the exception of a few 
CCs. M smegmatis did not grow in the presence of S9 at 21°C (Figure 5). C. albicans growth 
was considerably less in the presence of F1 compared to the other bat strains at 21°C (Figure 5). 
C. albicans also showed the same extent of growth with F1 at 37°C (Figure 6). S. aureus and M. 
smegmatis did not show growth in F1 CCs at 37°C (Figure 6). 
 
DISCUSSION 
Overview of Pathogenic Strains 
M. smegmatis 
There appeared to be issues with significant M. smegmatis growth in both temperature trials of 
the experiment. M.smegmatis in monoculture had visible colonies (Appendix 2). In CCs, 
colonies were transparent, with very little growth of visible colonies seen (Figure 3; Figure 4). 
For the purpose of this experiment, M. smegmatis growth measurements were inclusive of these 
‘transparent’ colonies. However, the success of bat strain growth against M. smegmatis cannot be 
attributed to possessing anti-mycobacterial properties. This is predominantly due to bat strain 
phenotypes in M. smegmatis CCs being quite similar to their phenotype in monoculture (Figure 
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3; Appendix 2). It is likely that what was observed in the M. smegmatis CCs were a dormant 
form of the bacteria, since a small area of bacterial growth was observed in certain CCs, such as 
that of F3 and S8 (Figure 3A; Figure 4A). Due to unfavourable conditions, M. smegmatis 
reverted to a dormant form upon inoculation from monoculture to CC.  
As is the case with many soil bacteria, M. smegmatis requires H2. Sequestering H2 
sustains respiratory cycles during the stationary phase of growth in many actinomycetes 
(Greening 2014). Aeration would have been beneficial for growth in M. smegmatis as to provide 
the essential atmospheric gasses it needs for cellular processes, along with an ideal nutritive 
medium such as MB7H10 (Prasad et al. 2019).  
M.smegmatis is also a difficult microbe to assess in relation to anti-mycobacterial 
properties in CCs due to its rather unusual mechanism of asymmetrical division compared to 
other bacilli bacteria. Mycobacteria do not possess the molecular mechanism that ensures the 
placement of the division septum is at the centre of the cell, resulting in an elongated mother cell 
and a smaller, circular daughter cell (Aldridge et al. 2012; Ginda et al. 2017). Chromosomes are 
not evenly segregated during division, resulting in genetically distinct subpopulations of 
Mycobacteria colonies. Heterogeneity in the population increases the difficulty in treating 
mycobacterial infections like tuberculosis (Aldridge et al. 2012). A heterogeneous population 
also represents a source of inconsistency when inoculating CCs.  
More CC trials involving bat strains must be conducted with M. smegmatis in order to 
properly assess the possibility of anti-mycobacterial properties within the bat strains.  
 
C.albicans and S. aureus  
C.albicans and S. aureus displayed similarities in the maintenance of growth and cell density in 
CC. Both pathogens generally displayed better growth in CCs at 21°C compared to 37°C (Figure 
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5; Figure 6). This observation does not lie in congruence with the optimal temperatures that were 
observed for both pathogens (Table 1). However, both S. aureus and C. albicans are considered 
to be successful pathogens due to their ability to survive in a wide range of environments 
including temperature fluctuations (Onyango et al. 2016; Sherwood et al. 2017; Du & Huang 
2016). 
Overall, the performance of C. albicans and S. aureus are relatively similar in the sense 
that these pathogens maintained their growth, though S. aureus better suppressed bat strain 
growth (Figure 4; Figure 5). The method in timing inoculation of CCs likely contributes to these 
findings. C. albicans was inoculated after providing the bat strains with a two-day head start 
because of its quick growth and robust properties as a microorganism.  
The ability to switch between phenotypes – yeast or hyphal – makes C. albicans an 
effective pathogen in various environments, including the human microbiome (Fonzi 2002). The 
yeast state is beneficial for propagation of growth, whereas the hyphal state switches on in 
instances of infection or to increase virulence (Du & Huang, 2016). Hyphae generally facilitate 
penetration of host cells in cases of infection (Fonzi 2002; Jarosz et al. 2009; Brand 2011). pH 
greatly influences the transition between the yeast-phase and the hyphal-phase; C. albicans 
assumes a yeast-structure in an acidic environment while filamentation occurs in a neutral to 
basic environment (Fonzi 2002) (Du & Huang 2016).  
Hyphae formation was not observed in C. albicans CCs, perhaps in part due to the pH of 
the media becoming slightly acidic in the presence of bat strains – since hyphal formation in C. 
albicans monocultures were observed in mature strains (Table 2; Appendix 2). It is also possible 
that the bat strains directly suppressed the ability of C. albicans to transverse into a hyphal form 
via QSM. There are other instances of microorganisms suppressing C. albicans hypha formation 
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through QSMs, such as the opportunistic bacterial pathogen Pseudomonas aruginosa (Jarosz et 
al., 2009). 
S. aureus has also been observed to undergo ‘phenotypic switching’ in periods of high 
stress such as low temperature (Onyango et al. 2012). S. aureus along with other staphylococcal 
species form ‘small colony variants’ (SCV) (Onyango et al. 2012; Mitchell et al. 2013). SCV 
contribute to virulence by increasing the rate of biofilm formation (Mitchell et al. 2013). SCV 
also produce distinct metabolites compared to their wild-type S. aureus counterparts (Wang & 
Zhu 2017). An increase in asymmetrical cell division is also seen in SCV (Onyngo et al. 2012). 
Asymmetrical division results in different composition of proteins and other cell wall 
components (Tropini, Rabbani & Huang 2012). So, the same effect in increased ability to 
respond to stress in environment as M. smegmatis is achieved by S. aureus. A great issue in 
treatment of Staphylococcal infections is the efficacy of drug delivery across biofilms 
(Mohammed et al. 2018). 
The colour pigmentation and cell wall composition of SCVs are altered in comparison to 
the original ‘wild-type’ colonies (Onyango et al. 2012; Guerillot et al, 2019). SCV are also 
characterized by slow growth compared to wild-type S. aureus (Guerillot et al, 2019). Though 
slow growth is not particularly exhibited in the case of this experiment, the phenotypic difference 
observed in S. aureus colonies at 21°C and 37°C could still be explained by the presence of SCV 
(Figure 3; Figure 4). There is great genetic diversity between SCVs, dependent on the response 
that the environment elicits from S. aureus colonies (Guerillot et al, 2019). 21°C is not the ideal 
temperature for S. aureus, though growth at this temperature remains. This coupled with the 
stress that a CC induces on microorganisms could provide a trigger for SCV formation in S. 
aureus.  
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There is also a difference in C. albicans morphology between temperatures. Smaller, 
circular white colonies occur at 21°C (Figure 3). Larger, cream coloured circular colonies occur 
at 37°C (Figure 4). This is less likely due to bat strain influence and more likely to do with 
temperature. The cellular appearance and morphology of C.albicans has been observed to change 
(Du & Huang 2016). A significant amount of exposure to heat effectively inhibits hyphal 
formation in C. albicans, which increases the effectiveness of antifungal medications (Ikezaki et 
al. 2019). 
Despite the slight difference in the success of S.aureus growth compared to C.albicans, 
this observed difference could be viewed as insignificant in terms of bat strain anti-pathogenic 
success. Both C.albicans and S.aureus posses properties such as phenotypic switching that 
contribute to their success as pathogens in colonizing an environment. In essence, an assertion of 
which pathogen is more resilient against bat strains cannot be made; but the anti-pathogenic 
potential of the bat strains themselves is slightly more conclusive. The extent of growth observed 
in bat strains in the presence of aggressive pathogens such as C. albicans and S. aureus show 
promise.  
Overview of Bat Strains 
Cell density as a function of Quorum-sensing 
This investigation is working under the presumption that QSM are secreted into the extracellular 
medium by a microorganism when it is in the presence of another microorganism. There are a 
few issues to consider within this framework of microbial interaction, specifically cell density of 
the microorganism and quantity of QSM. 
The rate of growth of any microorganism certainly has major implications in their ability 
to establish QS networks, at both the chemical and physical levels. First, more cells mean more 
QSM produced, which would propagate the intended effects of these molecules, whether it be to 
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increase virulence factors in a host or act as messengers to nearby organisms (Moreno-Gamez et 
al. 2017). In the initiation of a quorum-sensing network, autoinducers – a type of QSM – are 
released without the trigger of an environmental stress (Barrussio et al. 2018). The quantity of 
auto-inducers produced is directly proportional to the cell density of the microorganism 
(Moreno-Gomez et al. 2017). Once autoinducers reach a certain quantity in the ECE, quorum 
sensing with other microorganisms is commenced by triggering biofilm formation and/or the 
production of virulent QSM (Bettenworth et al. 2019).  
QSM, including autoinducers, produced by bat strains could potentially be more lethal 
against pathogens in higher quantities. The difference lies in the quantity at which the QSM are 
secreted; autoinducers are secreted in smaller quantities. When a threat is detected, the 
microorganism then increases the quantity of that autoinducer or other QSM, diffusing into the 
ECE with the purpose of initiating competition with a nearby microorganism (Bettenworth et al. 
2019).  
A high growth rate is beneficial in the natural environment where competition for resources is 
inherent due to the usual microorganism-rich habitats such as soil and water (Frey-Klett et al. 
2011). The relatively rapid growth rate of bat strains in this experiment could have provided 
these fungi with an advantage in colonizing an environment and secreting secondary-metabolites.  
F1 
Identified as Trichoderma spp., there is no data to date on the presence of possible anti-
pathogenic properties. F1 was the most successful bat strain in growth at both temperatures and 
in the presence of all three pathogens. The differences in phenotype between 21°C and 37°C 
could be attributed to spore formation. F1 at 21°C was not as mature since it grew optimally at 
37°C (Table 1; Table 2). Even in a less mature state, F1 was still effective in colonizing the 
entire plate in the presence of pathogens (Figure 3). This strain in particular poses a possibly 
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fruitful avenue of further investigation, given its ability to thrive in varying temperatures as well 
as effectively limiting the growth of C. albicans and S. aureus, which possess effective virulent 
factors themselves. 
F1’s success in CCs could be a result of its relatively high growth rate (Table 1), the 
production of anti-pathogenic secondary metabolites, or a combination of these two possibilities. 
F1 exhibits a rapid growth rate and with a high cell-density fungus, a larger quantity of QSM 
could theoretically be produced. It is possibility that some of these F1-produced QSM are anti-
pathogenic, yet this cannot be said for certain until these QSM are isolated and inserted into a 
growth medium with the pathogens in question.  
F3 
Identified as Didymella spp., there is no data to date on the presence of possible anti-pathogenic 
properties. Based on F3’s growth at both temperature trials in the presence of pathogens with the 
exception of S. aureus at 37°C, investigating this fungus is yet another avenue worth pursuing in 
future investigations. The hyphal extensions seen in both trials (Figure 3; Figure 4; Table 3; 
Table 4) are indicative of fungal growth. It is likely that F3 would eventually cover the entire 
plate, in similar fashion to F1, if the CCs were observed at a point where more time has elapsed. 
The formation of hyphae extending outwards is strong evidence for more significant growth to 
occur (Abubakar 2013). F3 can then be considered as yet another successful bat strain that can 
grow in the presence of pathogens, marking it as a possible source of anti-pathogenic metabolite 
production. 
S2  
To date, there has been no identification of S2. Based on its similar appearance to S9 in 
monoculture and CCs, it is likely that the two strains are closely related (Figure 3; Appendix 2). 
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There is a slight difference between S2 and S9 seen in the rate of growth in CCs. C. albicans 
exhibited a higher surface area of growth in S2 CC as opposed to S9 CC (Figure 5). Conversely, 
growth of S. aureus in S2 and S9 CCs are similarly ranked (Figure 5). Due to the lack of 
definitive data in differentiating the performance of S2 and S9 in CCs, more trials are needed to 
discern the difference between the two strains, if any. For the purpose of  this investigation, any 
discussion pertaining to observations of S9 in CC are applicable to S2.  
S8 
To date, there has been no identification of S8. Along with its S2 and S9 counterparts, S8 
showed minimal growth at 37°C (Figure 8). At 21°C, S8 exhibited more growth than F3 with S. 
aureus (Figure 3; Figure 7). Despite the larger growth seen in S8 compared to F3, this does not 
necessarily classify S8 as a possibly better anti-pathogenic microbe than F3. When considering 
growth coupled with phenotypic changes, F3 represents a better opponent of S. aureus than S8. 
Though surface area coverage is smaller in F3, hyphae are also observed (Table 3), indicating the 
continuation of growth.  
In contrast, S8 may have covered more area, but no hyphae are observed (Table 3). 
Growth of S8, then, could possibly have been halted since hyphae are the mechanism in which 
immobile fungi grow. Hyphae are seen in S8 x C. albicans as growth is continued (Figure 3). 
Despite the larger surface area covered by S8 x S. aureus, F3 remains a more promising avenue 
of study due to the high possibility of continued growth indicated by hyphae presence.  
S9  
Identified as Penicillium canescens, S9 is a soil fungus and forms mycorrhizal associations with 
plants (Sinitsyna et al. 2003). Documentation of its anti-pathogenic properties and possible 
explanations of the distinct coloration seen with C. albicans are also minimal (Figure 3). A 
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possible theory to explain the colour change from light pink to dark pink at the site of interaction 
with C. albicans could be the up-regulation of certain QSM in response to this pathogen’s 
presence. It could also be a reaction between S8 QSM and C. albicans QSM. Another 
explanation could be the production of spores. Sporulation, in addition to extension of hyphae, is 
another indicator of fungal growth (Abubakar 2013).  
It is difficult to discern sporulation or QSM production, due to the ‘reverse’ colour 
change seen in S9 x S. aureus compared to S9 x C. albicans (Figure 3A). S9 has patches of light 
pink at the pole of the plate, changing to a dark pink and then to a light pink along the outer 
edges where it comes into contact with S. aureus colonies (Figure 3A). S9 x C. albicans is light 
pink throughout, only turning dark pink at the site of interaction with C. albicans. The same 
difference in colour is observed in S2 x S. aureus and S2 x C. albicans (Figure 3A). There are a 
multitude of possible explanations that could be put forth, such as the possibility that S9 appears 
different in CC with S. aureus as a response to an increase of competition and stress. S9 grew to 
the full extent of the plate area in CC with C. albicans, which strongly supports the idea that a 
significant amount of stress was not inflicted on S9 by C. albicans.  
Considerations for Future Investigations 
Competition or Mutualism 
Another question these findings raise is whether the interaction between pathogen and bat strain 
is one of competition or one of mutualism/symbiosis. F1 and S9 were the only bat strains to 
encompass the plate, but pathogenic colonies remained visible (Figure 3A). There is a likelihood 
that this interaction between bat strain and pathogen is one of mutualism and not competition, 
decreasing the secretion of anti-pathogenic QSM molecule by the bat strains. To confirm 
competition, the isolated secondary metabolites or QSM produced in a bat strain x pathogen CC 
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could then be added in larger quantities to the growth medium for a pathogen monoculture. The 
presence of anti-pathogenic properties in the bat strains could then be accurately be observed.  
pH 
pH was a parameter that remained unaltered in this investigation. It is known that pH affects 
phenotypic switching in C. albicans and S. aureus (Sherrington et al. 2017). pH is considered a 
crucial signal for opportunistic pathogens in cases of infection, where changes in physical and 
metabolic changes can be seen (Sherrington et al. 2017).  
pH also affects growth and sporulation in most fungi, the majority of which prefer acidic 
environments (Abubakar et al. 2013). Spore production generally decreases in high pH, with the 
exception of a few fungal species, and mycelium growth is inhibited (Abubakar et al. 2013). 
Altering pH to potentially create a slightly less favourable environment for bat strains, in 
addition to competing for resources with pathogenic strains, could trigger stress-induced 
metabolic pathways in which secondary metabolites are secreted . 
Nutrition 
It is possible that YMA media, though it facilitated growth for the diverse selection of 
microorganisms studied in this experiment, did not favour the production of QSM in some 
strains. For example, Penicillium chrysogenum produces penicillin when glucose is used as a 
carbon source as opposed to lactose (Cepeda-Garcia et al. 2014). Altering carbon sources for the 
bat strains could possibly induce the production of QSM by triggering otherwise dormant 
pathways in the organism that responds to stress. 
CONCLUSION 
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There are endless combinations of parameters – temperature, nutrition, pH, aeration – that could 
elicit a stress response in microorganisms and, subsequently, the production of desired anti-
pathogenic secondary metabolites. Within the temperature, nutritional and time parameters set by 
this experiment, it was found that bat strains F1 and S9 show the most promise in anti-
pathogenic potential due to their ability to grow over the total surface of the plate after one week. 
F1 in particular greatly suppressed the growth of pathogens at both temperatures. F3 did not 
exhibit great growth but shows potential since it was continuing to grow past the one-week mark. 
The results of S2 CCs were nearly the same as those of S9. Identification of S2 is needed to 
confirm these strains are genetically distinct. S8 demonstrated potential anti-pathogenic 
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Area of growth calculations for 37°C trials (cm2) 
F1: 20.8  
S.aureus: < 1 
F1: 20.8 cm2 
M.smegmatis: 0 cm2 
F1: 20.8  
C.albicans: < 1  
F3: < 1  
S.aureus: 10.14 cm2 
F3: 6.96 cm2 
M.smegmatis: 8.74 cm2 
F3: 4.94  
C.albicans: 3.6 
S2: < 1 cm2 
S.aureus: 8.63 cm2 
S2: 1.08 cm2 
M.smegmatis: 7.98 cm2 
S2: < 1  
C.albicans: 3.38  
S8: < 1 cm2 
S.aureus: 7.35 cm2 
S8: 0.87 cm2 
M.smegmatis: 9.12 cm2 
S8: < 1  
C.albicans: 3.05  
S9: < 1 cm2 
S.aureus: 5.89 cm2 
S9: contaminated 
M.smegmatis: contaminated 
S9: < 1  
C.albicans: 9.52  
 
Area of growth calculations for 21°C trials (cm2) 
F1: 20.8  
S.aureus: 9.02  
F1: 20.8  
M.smegmatis: 9.31 



























Approximate area of monocultures:  
Bat strains: 20.8 cm2 (full plate area) 
S. aureus: 9.03 cm2 
M.smegmatis: 8.87 cm2 











Monocultures at ideal temperature after two weeks of growth 
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